Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform
Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
